Primaquine Diphosphate
63-45-6COc1cc(NC(C)CCCN)c2ncccc2c1.O=P(O)(O)O.O=P(O)(O)OGJOHLWZHWQUKAU-UHFFFAOYSA-NPrimaquine Phosphate is the phosphate salt form of primaquine, a synthetic, 8-aminoquinoline derivative with antimalarial properties. Although its mechanism of action is unclear, primaquine bind to and alter the properties of protozoal DNA. This agent eliminates tissue (exo-erythrocytic) malarial infection, preventing the development of the erythrocytic forms of the parasite which are responsible for relapses in Plasmodium vivax and ovale malaria. Primaquine is active against late hepatic stages (hypnozoites, schizonts).
63-45-6DTXSID6045248CHEMBL43128CHEBI:232993Breast Feeding; Lactation; Milk, Human; Anti-infective Agents; Antiparasitic Agents; Antimalarials; Antiprotozoal Agents
FDA approved drugs -> Active ingredient
FDA approved drugs -> Active ingredient
安全信息仅供参考,不能替代供应商安全技术说明书(SDS)、适用法规与专业评估。
Danger
H301 (100%): Toxic if swallowed [Danger Acute toxicity, oral]
P264, P270, P301+P316, P321, P330, P405, and P501 (click each P-code to see the statement)
Aggregated GHS information provided per 39 reports by companies from 2 notifications to the ECHA C&L Inventory.
Drug Induced Liver Injury Rank (DILIrank 2.0)
Primaquine phosphate
vNo-DILI-concern
0
No match
DOI:10.1016/j.drudis.2016.02.015
急性毒性口服-大鼠LD50: 177 毫克/公斤; 口服-小鼠LD50: 68 毫克/公斤
可燃性危险特性可燃;燃烧产生有毒氮氧化物和硫氧化物烟雾
储运特性库房通风低温干燥
灭火剂干粉、泡沫、砂土、二氧化碳, 雾状水
PRIMAQUINE PHOSPHATE
Antimalarial [EPC]
概述伯氨喹由Elderfield于1946年化学合成,并于1955年改良工艺,其成盐形式有磷酸盐与草酸盐两种,主要应用形式为磷酸伯氨喹,其药用价值很快被发现并应用于临床,作为抗疟药载入英美药典。磷酸伯氨喹于《中国药典》1963年版首次收载,此后每版《中国药典》均收载了该品种。据报道,磷酸伯氨喹对瑟氏泰勒虫和环形泰勒虫,有良好的杀灭效果,贝尼尔对牛瑟氏泰勒虫和环形泰勒虫有效,也有用磷酸伯氨喹和贝尼尔治疗羊泰勒虫病的报道,但治疗效果不尽一致。
用途抗疟药,用于控制间日疟与三日疟的复发和恶性疟的传播。